# A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer

> **NCT00255489** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 36 (—)

## Conditions studied

- Non-small-cell Lung Cancer

## Interventions

- **DRUG:** Gefitinib
- **PROCEDURE:** palliative thoracic radiotherapy

## Key facts

- **NCT ID:** NCT00255489
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 36 (—)
- **Last updated:** 2011-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255489, "A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00255489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*